Telemedicine Increases Access to Buprenorphine Initiation During the COVID-19 Pandemic
Discusses the expanded access to buprenorphine prescription through telemedicine during COVID-19, comparing the experiences of two harm reduction primary care programs in a rural and urban region of New York. Discusses reduced barriers to treatment, particularly delays due to in-person evaluation requirements before to the pandemic, and innovations to opioid use disorder treatment made possible through telehealth.
Linda Wang, Jeffrey Weiss, Elizabeth Bogel Ryan, et al.
Journal of Substance Abuse Treatment, 124, 108272
Access · Illicit drug use · Prescription drug misuse · Rural-urban differences · Substance use and misuse · Telehealth · New York